Antinociceptive interactions of ketamine with morphine or methadone in mononeuropathic rats

European Journal of Pharmacology

Volumn 477, Issue 1, 2003, Pages 23-28

  Pelissier, Teresa ^a   Laurido, Claudio ^b   Kramer, Verónica ^a   Hernández, Alejandro ^b   Paeile, Carlos ^a  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

Author keywords

(Rat); Isobologram; Ketamine; Methadone; Mononeuropathy; Morphine; Pain; Paw pressure

Indexed keywords

KETAMINE; METHADONE; MORPHINE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; OPIATE AGONIST;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; EVALUATION; MONONEUROPATHY; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT; SCIATIC NERVE; VEIN LIGATION;

ANALGESICS; ANIMALS; BEHAVIOR, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; INJECTIONS, SUBCUTANEOUS; KETAMINE; MALE; METHADONE; MONONEUROPATHIES; MORPHINE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID; RECEPTORS, OPIOID, MU;

EID: 1642404727     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(03)02192-7     Document Type: Article

References (27)

1. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
2. Bespalov A.Y., Zvartau E.E., Beardsley P.M. Opioid-NMDA receptor interactions may clarify conditioned (associative) components of opioid analgesic tolerance. Neurosci. Biobehav. Rev. 25:2001;343-353.
3. Chapman V., Dickenson A.H. The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn. Brain Res. 573:1992;321-323.
4. Crain S.M., Shen K. Acute thermal hyperalgesia elicited by low-dose morphine in normal mice is blocked by ultra-low-dose naltrexone, unmasking potent opioid analgesia. Brain Res. 888:2001;75-82.
5. Dickenson A.H. A cure for wind up: NMDA receptor antagonists as potential analgesics. Trends Pharmacol. Sci. 11:1990;307-309.
6. Dickenson A.H., Aydar E. Antagonism at the glycine site on the NMDA receptor reduces spinal nociception in the rat. Neurosci. Lett. 121:1991;263-266.
7. Dickenson A.H., Chapman V., Green G.M. The pharmacology of excitatory and inhibitory amino acid-mediated events in the transmission and modulation of pain in the spinal cord. Gen. Pharmacol. 28:1997;633-638.
8. Eide P.K. Wind-up and the NMDA receptor complex from a clinical perspective. Eur. J. Pain. 4:2000;5-15.
9. Fields H.L., Rowbotham M.C. Multiple mechanisms of neuropathic pain: a clinical perspective. Gebhart G.F., Hammond D.L., Jensen T.S. Progress in Pain Research and Management. vol. 2:1994;437-454 IASP Press, Seattle.
10. Grass S., Hoffmann O., Xu X.J., Wiesenfeld-Hallin Z. N-methyl-D- aspartate receptor antagonists potentiate morphine's antinociceptive effect in the rat. Acta Physiol. Scand. 158:1996;269-273.
11. Haley J.E., Sullivan A.F., Dickenson A.H. Evidence for spinal N-methyl-D-aspartate receptor involvement in prolonged chemical nociception in the rat. Brain Res. 518:1990;218-226.
12. Hoffmann O., Wiesenfeld-Hallin Z. Dextromethorphan potentiates morphine antinociception, but does not reverse tolerance in rats. NeuroReport. 7:1996;838-840.
13. Kayser V., Guilbaud G. Differential effects of various doses of morphine and naloxone on two nociceptive test thresholds in arthritic and normal rats. Pain. 41:1990;353-363.
14. Laulin J.P., Maurette P., Corcuff J.B., Rivat C., Chauvin M., Simonnet G. The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance. Anesth. Analg. 94:2002;1263-1269.
15. Mao J. NMDA and opioid receptors: their interactions in antinociception, tolerance and neuroplasticity. Brain Res. Rev. 30:1999;289-304.
16. Meyerson B.A., Ren B., Herregodts P., Linderoth B. Spinal cord stimulation in animal models of mononeuropathy: effects on the withdrawal response and the flexor reflex. Pain. 61:1995;229-243.
17. Nichols M.L., Lopez Y., Ossipov M.H., Bian D., Porreca F. Enhancement of the antiallodynic and antinociceptive efficacy of spinal morphine by antisera to dynorphin A (1-13) or MK-801 in a nerve-ligation model of peripheral neuropathy. Pain. 69:1997;317-322.
18. Nishiyama T. Interaction between intrathecal morphine and glutamate receptor antagonists in formalin test. Eur. J. Pharmacol. 395:2000;203-210.
19. Nishiyama T., Yaksh T.L., Weber E. Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine. Anesthesiology. 89:1998;715-722.
20. Olivar T., Laird J.M. Differential effects of N-methyl-D-aspartate receptor blockade on nociceptive somatic and visceral reflexes. Pain. 79:1999;67-73.
21. Randall P.O., Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. 111:1957;409-419.
22. Shen K.F., Crain S.M. Cholera toxin-B subunit blocks excitatory opioid receptor-mediated hyperalgesic effects in mice, thereby unmasking potent opiod analgesia and attenuating opiod tolerance/dependence. Brain Res. 919:2001;20-30.
23. Tallarida, R.J., 2000. Drug synergism and dose-effect data analysis. Chapman & Hall/CRC Press, Boca Raton, pp. 57-75.
24. Tallarida R.J., Porreca F., Cowan A. Statistical analysis of drug-drug and site-site interactions with isobolograms. Life Sci. 45:1989;947-961.
25. Wiesenfeld-Hallin Z. Combined opioid-NMDA antagonist therapies. What advantages do they offer for the control of pain syndromes? Drugs. 55:1998;1-4.
26. Yamamoto T., Yaksh T.L. Comparison of the antinociceptive effects of pre- and posttreatment with intrathecal morphine and MK801, an NMDA antagonist, on the formalin test in the rat. Anesthesiology. 77:1992;757-763.
27. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.